Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Quorum Bio develops engineered microbial solutions to promote crop growth, enhance stress tolerance (e.g., drought), control plant disease, improve nutrient acquisition, and increase carbon sequestration. Their proprietary synthetic biology platform allows them to engineer a wide range of non-model plant-associated microbes at unprecedented speed and scale. The company’s products are designed as sustainable alternatives to chemical fertilizers/pesticides. They are an early-stage startup with support from the Activate Fellowship and venture investors; no commercial products or clinical trial results have been announced yet.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Quorum Bio.